UBS Group’s Zogenix, Inc. ZGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-2,221
| Closed | -$36K | – | 11623 |
|
|
2021
Q4 | $36K | Buy |
2,221
+1,121
| +102% | +$16.4K | ﹤0.01% | 7219 |
|
|
2021
Q3 | $17K | Buy |
1,100
+997
| +968% | +$15.6K | ﹤0.01% | 7402 |
|
|
2021
Q2 | $2K | Buy |
103
+3
| +3% | +$55 | ﹤0.01% | 9111 |
|
|
2021
Q1 | $2K | Hold |
100
| – | – | ﹤0.01% | 8732 |
|
|
2020
Q4 | $2K | Sell |
100
-1,406
| -93% | -$28.7K | ﹤0.01% | 8182 |
|
|
2020
Q3 | $27K | Sell |
1,506
-5,123
| -77% | -$126K | ﹤0.01% | 6088 |
|
|
2020
Q2 | $179K | Buy |
6,629
+6,413
| +2,969% | +$177K | ﹤0.01% | 4882 |
|
|
2020
Q1 | $5K | Sell |
216
-24,807
| -99% | -$903K | ﹤0.01% | 7359 |
|
|
2019
Q4 | $1.3M | Buy |
25,023
+23,111
| +1,209% | +$1.06M | ﹤0.01% | 3964 |
|
|
2019
Q3 | $77K | Buy |
1,912
+1,416
| +285% | +$65.3K | ﹤0.01% | 5926 |
|
|
2019
Q2 | $24K | Sell |
496
-50
| -9% | -$2.01K | ﹤0.01% | 6506 |
|
|
2019
Q1 | $30K | Sell |
546
-468
| -46% | -$22.3K | ﹤0.01% | 5963 |
|
|
2018
Q4 | $37K | Sell |
1,014
-436
| -30% | -$17.9K | ﹤0.01% | 6340 |
|
|
2018
Q3 | $72K | Buy |
1,450
+1,122
| +342% | +$57.1K | ﹤0.01% | 5865 |
|
|
2018
Q2 | $15K | Buy |
328
+28
| +9% | +$1.15K | ﹤0.01% | 6920 |
|
|
2018
Q1 | $12K | Sell |
300
-2,065
| -87% | -$81.9K | ﹤0.01% | 6794 |
|
|
2017
Q4 | $95K | Sell |
2,365
-88,388
| -97% | -$3.4M | ﹤0.01% | 5393 |
|
|
2017
Q3 | $3.18M | Buy |
90,753
+89,953
| +11,244% | +$1.22M | ﹤0.01% | 2647 |
|
|
2017
Q2 | $12K | Hold |
800
| – | – | ﹤0.01% | 6686 |
|
|
2017
Q1 | $9K | Sell |
800
-1,011
| -56% | -$10.2K | ﹤0.01% | 6727 |
|
|
2016
Q4 | $22K | Sell |
1,811
-785
| -30% | -$8.62K | ﹤0.01% | 6477 |
|
|
2016
Q3 | $30K | Buy |
2,596
+878
| +51% | +$8.1K | ﹤0.01% | 5954 |
|
|
2016
Q2 | $13K | Sell |
1,718
-2,842
| -62% | -$27.7K | ﹤0.01% | 6653 |
|
|
2016
Q1 | $42K | Buy |
4,560
+3,712
| +438% | +$37.2K | ﹤0.01% | 5640 |
|
|
2015
Q4 | $12K | Buy |
848
+318
| +60% | +$4.28K | ﹤0.01% | 7202 |
|
|
2015
Q3 | $7K | Sell |
530
-2,951
| -85% | -$53.2K | ﹤0.01% | 7558 |
|
|
2015
Q2 | $47K | Sell |
3,481
-18
| -0.5% | -$221 | ﹤0.01% | 6062 |
|
|
2015
Q1 | $38K | Buy |
3,499
+2,473
| +241% | +$28K | ﹤0.01% | 6314 |
|
|
2014
Q4 | $11K | Buy |
+1,026
| New | +$10.2K | ﹤0.01% | 8358 |
|
UBS Group's ZGNX Position: Q1 2022 in Review
UBS Group sold out of Zogenix, Inc. (ZGNX) in Q1 2022, closing a stake of 2,221 shares — an estimated $36K sold.
UBS Group first reported a position in ZGNX in Q4 2014 and held it in 29 quarters. The position peaked at $3.18M in Q3 2017. 0 funds tracked by Wall St. Rank hold ZGNX as of Q1 2022.
- UBS Group reported no remaining Zogenix, Inc. position as of Q1 2022 after selling out during the quarter.
- UBS Group sold 2,221 Zogenix, Inc. shares in Q1 2022, an estimated $36K.
- UBS Group first reported a position in Zogenix, Inc. in Q4 2014 and held it in 29 quarters.
- UBS Group's Zogenix, Inc. position peaked at $3.18M in Q3 2017.
- 0 funds tracked by Wall St. Rank held Zogenix, Inc. as of Q1 2022.
Based on UBS Group's 13F filing for Q1 2022, filed 16 May 2022.